Tyra Biosciences, Inc.

Healthcare · Biotechnology · United States

Last price 21.07 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.45B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumor...